CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | March/April 2021

2020 ACC/AHA Guideline for Management of Patients With Valvular Heart Disease

Experts share their views on how these new guidelines will impact practice.

With Gorav Ailawadi, MD; Mario J. Garcia, MD, FACC; Rishi Puri, MD, PhD; and Vinod H. Thourani, MD

cit | Article | March/April 2021

Contemporary Issues in TAVR

By James McCabe, MD, and Darren Mylotte, MD

cit | Article | May/June 2011

How Do OCT and IVUS Differ?

A comparison and assessment of these modern imaging modalities.

By Joshua Waggoner, MD, and Marc D. Feldman, MD, FACC, FSCAI

cit | Article | May/June 2022

Update on Near-Infrared Spectroscopy/Intravascular Ultrasound

The fundamental aspects and current clinical roles.

By Selcuk Kucukseymen, MD; Francesca Ciatti, MD; Niccolò Ciardetti, MD; Alessio Mattesini, MD; and Carlo Di Mario, MD, PhD

Advertisement

Advertisement

cit | Article | January/February 2013

Potential Use of OCT Imaging in Clinical Practice

From preintervention to postprocedure follow-up, the utility of optical coherence tomography assessment is examined.

By Daniel Chamié,, MD, and Ricardo A. Costa, MD, PhD

cit | Article | July/August 2010

High-Resolution Lesion Assessment With OCT

What every interventional cardiologist needs to know about this FDA-approved imaging modality.

By Sahil A. Parikh, MD, and Marco A. Costa, MD, PHD

cit | Article | January/February 2020

Novel Nonpharmacologic Therapies for Patients With Refractory Angina Pectoris

A review of available treatment options.

By Francesco Gallo, MD; Francesco Ponticelli, MD; Antonio Colombo, MD; and Francesco Giannini, MD

cit | Article | May/June 2020

Clinical Implications and Treatment of Coronary Microvascular Obstruction in STEMI

The unmet need of effectively targeting MVO to improve clinical outcomes.

By Rocco A. Montone, MD, PhD, and Filippo Crea, MD, PhD, FESC, FACC

cit | Article | September/October 2011

The CoreValve Program

Cardiac Interventions Today interviews Carlos E. Ruiz, MD, PhD, who shares his expertise on the current status of the CoreValve device and trial data.

cit | Article | May/June 2011

IVUS With Virtual Histology in Clinical Practice

A novel imaging technology for assessing vulnerable plaque.

By Adnan Khalid, MD, and Steven P. Marso, MD

cit | Article | July/August 2015

Identification of Vulnerable Plaques

Various imaging methods allow evaluation in vivo.

By Daisuke Nakamura, MD; Setsu Nishino, MD, PhD; Guilherme F. Attizzani, MD; Hiram G. Bezerra, MD, PhD; and Marco A. Costa, MD, PhD

cit | News | September 30, 2009

PCI for the Left Main Coronary Artery

With the availability of drug-eluting stents (DES) and the dramatic reduction in restenosis rates they have provided, the results of left main coronary artery (LMCA) stenting have certainly improved compared to preliminary experiences with bare-metal stents (BMS), which were limited by high restenosis rates and sudden deaths.1-6 Encouraging results have been reported at midterm clinical follow-up in some observational registries with elective DES implantation in the LMCA, with a 1-year mortality rate of 0% to 5%.7-12 In these registries, the need for target lesion revascularization (TLR) varied from 0% to 14%, and target vessel revascularization (TVR) varied from 0% to 19%.

cit | Article | September/October 2018

Challenging Cases: What Would You Do?

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Shakeel A. Qureshi, MD, FRCP, FRCPCH

cit | Article | March/April 2014

Structural Heart Interventions

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | January/February 2010

PCI Strategies After Fibrinolytic Therapy

How to choose the appropriate reperfusion strategy.

By Michel R. Le May, MD


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button